Product image of Karissa Zilnic (Ethinylestradiol, Gestodene | Lactose) supplied by GNH India

Karissa Zilnic

Active Ingredient:
Ethinylestradiol, Gestodene | Lactose
Origin:
EU

Karissa Zilnic (Ethinylestradiol, Gestodene | Lactose)

Ethinylestradiol and gestodene, the active ingredients in Karissa Zilnic, are a combined oral contraceptive presented as a tablet for oral use. The formulation is approved in the European Union and is indicated for the prevention of pregnancy in women of reproductive age.

GNH India supplies Karissa Zilnic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our operations follow stringent quality assurance protocols and regulatory compliance to ensure consistent product integrity across all markets through reliable logistics networks.

Manufacturer / TM Owner

Gedeon Richter România S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Karissa Zilnic is a combined hormonal contraceptive that works within the reproductive hormone pathway to prevent pregnancy.

  • Prevention of pregnancy: provides reliable contraceptive protection when taken as prescribed.
  • Menstrual cycle regulation: helps achieve more predictable bleeding patterns.
  • Management of dysmenorrhea: reduces menstrual pain associated with ovulatory cycles.

How It Works

  • Ethinylestradiol and gestodene suppress ovulation by inhibiting the mid‑cycle surge of luteinising hormone (LH) and follicle‑stimulating hormone (FSH). The estrogen component stabilises the endometrial lining, while the progestogen component thickens cervical mucus and alters the endometrium, creating an environment that prevents fertilisation and implantation.

Side Effects

Karissa Zilnic may cause a range of adverse reactions. Most are mild and transient.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Breast tenderness: temporary swelling or discomfort.
  • Headache: occasional dull or throbbing pain.
  • Spotting or breakthrough bleeding: irregular light bleeding.
  • Weight gain: modest increase in body weight.
  • Mood changes: irritability or mood swings.

Serious or Rare Side Effects

  • Venous thromboembolism: blood clots in deep veins.
  • Arterial thrombosis: clot formation in arteries, potentially leading to stroke.
  • Hypertension: elevated blood pressure.
  • Hepatic adenoma: benign liver tumor.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Visual disturbances: sudden changes in vision.

Precautions & Warnings

Before prescribing Karissa Zilnic, clinicians should consider several safety factors.

  • Contraindications: avoid in women with a history of thromboembolic disorders, estrogen‑dependent tumors, or active liver disease.
  • Smoking: contraindicated in women over 35 who smoke, due to increased cardiovascular risk.
  • Cardiovascular risk: assess for hypertension, hyperlipidaemia, or atherosclerotic disease.
  • Liver disease: use with caution in patients with hepatic impairment.
  • Medication review: evaluate concomitant drugs that may affect hormonal metabolism.
  • Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Karissa Zilnic can interact with several medicines that alter hormone levels or increase clotting risk.

Major Interactions (Avoid)

  • Strong enzyme inducers (e.g., rifampin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.
  • Certain antifungals (e.g., ketoconazole): can increase estrogen exposure, raising the risk of side effects.
  • St. John’s wort: may lower plasma concentrations of the active hormones.

Moderate Interactions (Monitor Closely)

  • Broad‑spectrum antibiotics (e.g., ampicillin): may slightly diminish effectiveness.
  • SSRIs (e.g., fluoxetine): can increase bleeding tendency.
  • Antihypertensives (e.g., ACE inhibitors): may have additive blood‑pressure effects.

Frequently Asked Questions

Karissa Zilnic is a combined oral contraceptive containing ethinylestradiol and gestodene. It is prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation and creating conditions that are unfavorable for fertilisation and implantation.

The estrogen component, ethinylestradiol, stabilises the endometrial lining, while the progestogen gestodene suppresses the mid‑cycle surge of luteinising hormone (LH) and follicle‑stimulating hormone (FSH). This dual action prevents ovulation and alters cervical mucus and the uterine lining, reducing the chance of fertilisation and implantation.

The dosing regimen for Karissa Zilnic is determined by the prescribing healthcare professional. Typically, combined oral contraceptives are taken once daily at the same time for a 21‑day active tablet series followed by a placebo or hormone‑free interval, but the exact schedule must be set by the prescriber.

Karissa Zilnic is intended for use only when pregnancy is not desired. It should not be started during an existing pregnancy, and if pregnancy occurs, the product must be discontinued. Limited data are available for breastfeeding; clinicians usually advise against use while nursing unless the benefits outweigh potential risks.

To order Karissa Zilnic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any necessary import documentation.

Karissa Zilnic contains ethinylestradiol and gestodene, a low‑dose progestogen that offers a favorable bleeding profile and lower androgenic activity compared with some older formulations. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives, while the side‑effect profile may differ slightly based on individual hormone sensitivity.

Karissa Zilnic tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Karissa Zilnic is taken orally, usually once each day at the same time. The usual regimen involves a series of active tablets followed by a hormone‑free interval, but the exact schedule should be confirmed with the prescribing clinician.

Serious risks include venous or arterial thromboembolism, hypertension, hepatic adenoma, and severe allergic reactions. Women with a history of clotting disorders, smoking over age 35, or certain cardiovascular conditions should avoid this product or use it only under close medical supervision.

Karissa Zilnic is contraindicated in women with known or suspected pregnancy, active liver disease, estrogen‑dependent tumors, a history of thromboembolic events, or those who are smokers over 35 years of age. It should also be avoided in individuals with known hypersensitivity to any component of the tablet.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Gestodene | Lactose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT